Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3041943rdf:typepubmed:Citationlld:pubmed
pubmed-article:3041943lifeskim:mentionsumls-concept:C0206194lld:lifeskim
pubmed-article:3041943lifeskim:mentionsumls-concept:C0439660lld:lifeskim
pubmed-article:3041943lifeskim:mentionsumls-concept:C0151779lld:lifeskim
pubmed-article:3041943lifeskim:mentionsumls-concept:C0035335lld:lifeskim
pubmed-article:3041943pubmed:issue8lld:pubmed
pubmed-article:3041943pubmed:dateCreated1988-9-1lld:pubmed
pubmed-article:3041943pubmed:abstractTextSix survivors of bilateral retinoblastoma developed cutaneous malignant melanoma 20 to 51 years (average, 31 years) after initial therapy for the ocular tumor. Five patients received radiation therapy to the orbital area. In two patients the cutaneous malignant melanoma developed in the field of irradiation. Two patients developed multiple cutaneous melanomas and are thought to have the dysplastic nevus syndrome. At this writing two patients are alive and well after wide resection of their skin tumors. A review of the literature suggests that cutaneous malignant melanoma accounts for about 7% of second malignant neoplasms in survivors of heritable retinoblastoma.lld:pubmed
pubmed-article:3041943pubmed:languageenglld:pubmed
pubmed-article:3041943pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3041943pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3041943pubmed:statusMEDLINElld:pubmed
pubmed-article:3041943pubmed:monthAuglld:pubmed
pubmed-article:3041943pubmed:issn0003-9950lld:pubmed
pubmed-article:3041943pubmed:authorpubmed-author:ZimmermanL...lld:pubmed
pubmed-article:3041943pubmed:authorpubmed-author:ManzH JHJlld:pubmed
pubmed-article:3041943pubmed:authorpubmed-author:TraboulsiE...lld:pubmed
pubmed-article:3041943pubmed:issnTypePrintlld:pubmed
pubmed-article:3041943pubmed:volume106lld:pubmed
pubmed-article:3041943pubmed:ownerNLMlld:pubmed
pubmed-article:3041943pubmed:authorsCompleteYlld:pubmed
pubmed-article:3041943pubmed:pagination1059-61lld:pubmed
pubmed-article:3041943pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:meshHeadingpubmed-meshheading:3041943-...lld:pubmed
pubmed-article:3041943pubmed:year1988lld:pubmed
pubmed-article:3041943pubmed:articleTitleCutaneous malignant melanoma in survivors of heritable retinoblastoma.lld:pubmed
pubmed-article:3041943pubmed:affiliationDepartment of Ophthalmology, Georgetown University Medical Center, Washington, DC 20007.lld:pubmed
pubmed-article:3041943pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3041943pubmed:publicationTypeReviewlld:pubmed
pubmed-article:3041943pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3041943lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3041943lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3041943lld:pubmed